登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Cadherin-17】

Cadherin-17信息

英文名称:Cadherin-17
中文名称:钙粘蛋白17
靶点别称:Liver-intestine cadherin,HPT-1,CDH16,Intestinal peptide-associated transporter HPT-1,LI-cadherin,HPT-1 Cadherin,Cadherin 17, LI Cadherin (Liver-Intestine),HPT1,Human Intestinal Peptide-Associated Transporter HPT-1,LI Cadherin,Cadherin,Cadherin 17,Human Peptide Transporter 1,Cadherin-16
上市药物数量:0
临床药物数量:2
最高研发阶段:临床一期

Cadherin-17产品列表

ACRO质量管理体系
 
评论(2)
CA7-H52H3|Human Cadherin-17 / CDH17 Protein, His Tag
  1. 182XXXXXXX6
  2. 0人赞
  3. 购买cadherin17靶点抗原重组蛋白,主要用于相关单克隆抗体亲和力检测,与同行产品相比活性较高,不同批次间产品质量统一性好,性价比高,值得推荐!
  4. >
  5. 2023-02-11
CA7-H52E6|Biotinylated Human Cadherin-17 / CDH17 Protein, His,Avitag™ (MALS verified)
  1. 135XXXXXXX6
  2. 0人赞
  3. 购买生物素标记的CDH17蛋白用于Elisa实验和SPR实验,蛋白经过了MALS验证,符合实验的需求。该蛋白纯度高,稳定性好,生物素标记率高,后续会持续购买。
  4. 2022-11-30
 

Cadherin-17分子别名

Cadherin-17,CDH17,HPT-1, LI-cadherin

Cadherin-17分子背景

Cadherin-17, also known as liver-intestine (LI) Cadherin, belongs to the cadherin family of calcium-dependent cell adhesion molecules. In vivo studies showed CDH17 knockout resulted in apoptotic PC tumor death through activating caspase-3 activity. Taken together, CDH17 functions as an oncogenic molecule critical to PC growth by regulating tumor apoptosis signaling pathways and CDH17 could be targeted to develop an anti-PC therapeutic approach.

Cadherin-17临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
ARB-202 ARB-202 临床一期 Arbele Corp 肝癌, 胆管癌, 胃癌, 胰腺癌, 胆管上皮癌, 结直肠癌, 胃肠道癌症 详情
BI-905711 BI-905711 临床一期 Boehringer Ingelheim Gmbh 胰腺癌, 胆管上皮癌, 胃肠道癌症 详情

消息提示

请输入您的联系方式,再点击提交!

确定